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Molecular Cytogenetic Applications in Analysis 
of the Cancer Genome
Pulivarthi H. Rao, Subhadra V. Nandula, and Vundavalli V. Murty
Summary
Cancer cells exhibit nonrandom and complex chromosome abnormalities. The role of genomic
changes in cancer is well established. However, the identification of complex and cryptic chromo-
somal changes is beyond the resolution of conventional banding methods. The fluorescence
microscopy afforded by imaging technologies, developed recently, facilitates a precise identifica-
tion of these chromosome alterations in cancer. The three most commonly utilized molecular cyto-
genetics methods comparative genomic hybridization, spectral karyotype, and fluorescence in situ
hybridization, that have already become benchmark tools in cancer cytogenetics, are described in
this chapter. Comparative genomic hybridization is a powerful tool for screening copy-number
changes in tumor genomes without the need for preparation of metaphases from tumor cells.
Multicolor spectral karyotype permits visualization of all chromosomes in one experiment permit-
ting identification of precise chromosomal changes on metaphases derived from tumor cells. The
uses of fluorescence in situ hybridization are diverse, including mapping of alteration in single
copy genes, chromosomal regions, or entire chromosomes. The opportunities to detect genetic
alterations in cancer cells continue to evolve with the use of these methodologies both in diagno-
sis and research. 
Key Words: Cancer; chromosome aberrations; comparative genomic hybridization; fluores-
cence in situ hybridization; spectral karyotyping; molecular cytogenetics. 
1. Introduction
The cancer cell accumulates a number of genetic changes during the
process of tumor initiation and progression. In order to understand the fun-
damental biology of cancer, it is essential to identify as many of these
genetic alterations during cancer development as possible. Theodor Boveri’s
hypothesis in 1914 that chromosome abnormalities play a central role in
transformation of normal cell to neoplastic cell laid the foundation for the
current understanding of chromosomal basis of cancer. Therefore, it is criti-
cal to identify chromosomal changes in the tumor genome to accrue knowl-
edge of molecular mechanisms of the neoplastic process. 
Conventional cytogenetic analysis is one of the most widely accepted DNA
genome-screening tools for identification of chromosomal aberrations in cancer
cells. However, there are two built-in limitations to conventional cytogenetic
analysis. One limitation is representation. The success rate of detection of clon-
ally abnormal karyotypes in short-term cultures of most types of tumors is low.
Such a low cytogenetic success rate introduces a bias in representation of true
genetic aberration in the tumor genome. The other limitation is complexity. In
addition to recognizable chromosomal aberrations, most tumors exhibit marker
chromosomes whose derivation is difficult to determine by conventional cyto-
genetic analysis, which introduces another level of bias. To overcome these limit-
ations a host of molecular cytogenetic techniques such as fluorescence in situ
hybridization (FISH), comparative genomic hybridization (CGH), multicolor
spectral karyotype (SKY)/multicolor FISH (m-FISH), and array-based CGH
have recently been developed (1–9). In this chapter, detailed methodologies and
limitations of three of the most commonly used molecular cytogenetic methods
in the analysis of the cancer genome are discussed (Table 1).
2. Materials
2.1. Preparation of Human Lymphocyte Metaphase Chromosomes
1. RPMI medium 1640 (GIBCO, Invitrogen, Carlsbad, CA; cat. no. 21870-076).
2. L-Glutamine 200 mM (GIBCO, cat. no. 25030-081), 100 mL (make 5-mL aliquots;
add 5–500 mL medium).
3. Penicillin/streptomycin (GIBCO, cat. no. 15070-063) (make 5-mL aliquots; add
5–500 mL medium).
4. Fetal bovine serum qualified, heat inactivated (GIBCO, cat. no. 16140-071).
5. Phytohaemagglutinin (PHA) lyophilized (GIBCO, cat. no. 10576-015). (Rehydrate
with 10 mL of sterile double-distilled [dd]H2O and store at [20°C].)
6. Colcemid, KaryoMAX Colcemid (10 μg/mL) (GIBCO, cat. no. 15210-040).
2.2. Preparation of Labeled DNA Probes for CGH
1. 10X Nucleotide mix (see item 31).
2. 25 μM dTTP (Roche Diagnostics, Indianapolis, IN; cat. no. 105 1482).
3. 25 μM dATP (Roche Diagnostics, cat. no. 105 1440).
4. 25 μM dGTP (Roche Diagnostics, cat. no. 105 1466).
5. 25 μM dCTP (Roche Diagnostics, cat. no. 105 1458).
6. Fluorescein 12-dUTP (Dupont NEN, Boston, MA; cat. no. NEL-413).
7. Texas Red 5-dUTP (Dupont NEN, cat. no. NEL-417).
8. DNA polymerase I (0.5 U/μL/0.4 mU/μL DNase I) (Invitrogen, cat. no. 18162016).
9. DNA polymerase I (10 U/μL) (Invitrogen, cat. no. 18010025).
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10. DNase I type II (Sigma, St. Louis, MO; cat. no. D4527).
11. 2-Mercaptoethanol (Sigma, cat. no. M6250).
12. Agarose (Sigma, cat. no. A9539).
13. G-50 Sephadex columns (Roche Diagnostics, cat. no. 1523023).
14. Pepsin (Sigma, cat. no. P6887).
15. Human Cot-1 DNA (Invitrogen, cat. no. 15279-011).
16. Lambda DNA/Hind III marker (Promega, Madison, WI; cat. no. G1711).
17. Formamide (Fisher, cat. no. F84-1).
18. 4′,6-diamidino-2-phenylindole (DAPI) (Sigma, cat. no. D-9542).
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Table 1
Advantages and Limitations of Various Molecular Cytogenetic Techniques
Fluorescent in situ Comparative genomic Spectral karyotyping 
hybridization (FISH) hybridization (CGH) (SKY)
Advantages
Highly specific Global view of chromosomal Detects complex and 
and sensitive losses, gains, and cryptic chromosomal 
amplifications translocations
Mapping of genes No need for chromosomes Defines the origin of 
to chromosomes from clinical samples and markers, hsrs and double 
requires only a small minute chromosomes.
amount of DNA (~2 μg) Sensitive to detect 
deletions 10 to 15 mb
Detects deletions, Sensitive to detect deletions Detects the chromosomal
inversions, 10–15 mb boundaries in 
numerical changes, interphase nuclei
and translocations 
in interphase nuclei 
and metaphase 
chromosomes
Sensitive to detect 
deletions >1 kb
Limitations
Highly focused, prior Unable to detect balanced Cannot detect inversions 
knowledge of translocations and and duplications of 
gene(s) is inversions specific band(s) and 
required Detects abnormalities only subtle deletions
if the tumor cells are 
greater than 50% of 
the specimen
22. Rubber sealant.
23. Water baths (37, 45, and 75°C).
24. Circulating water bath (15°C) or PCR thermal cycler.
25. Glass slides, 22-mm2 and 24 × 50-mm2 cover slips.
26. Vertical Coplin jars.
27. DAPI Stock solution (100 μg/mL):
a. Dissolve 1 mg DAPI in 10 mL of ddH2O. Add few drops of methanol to dis-
solve DAPI before adding ddH2O. Store at −20°C.
b. Working solution: add 1–2 μL of DAPI stock solution to 1 mL of antifade
mounting medium (VECTASHIELD mounting medium). Aliquot into small
brown tubes and store at −20°C.
28. Denaturation solution (pH 7.0):
a. 350 mL Formamide.
b. 50 mL 20X SSC.
c. 100 mL ddH2O.
d. Stir well and adjust pH to 7.0 if necessary with 1 N HCl. Store at 4°C.
29. DNase working solution:
a. Stock solution: dissolve 3 mg of DNase in 1 mL of 0.15 M NaCl and 50% gly-
cerol. Aliquot 100-μL volumes into small tubes and store at −20°C.
b. Working solution: add 1 μL stock solution to ice cold 500 μL ddH2O immedi-
ately before use, discard after each use (see Note 1).
30. Master hybridization buffer (pH 7.0):
a. 5 mL Formamide.
b. 1 mL 20X SSC.
c. 1 gm Dextran sulfate.
d. Make up to 10 mL with ddH2O.
e. Filter through 0.22-μ filter and store at –20°C.
31. 10X Nucleotide mix:
a. 100 μL 10 mM dATP.
b. 100 μL 10 mM dGTP.
c. 100 μL 10 mM dCTP.
d. 2.5 mL Tris-HCl (pH 7.2).
e. 250 μL 1 M MgCl2.
f. 34 μL 14.7 M 2-Mercaptoethanol.
g. 50 μL 10 mg/mL Bovine serum albumin.
h. 1.866 mL ddH2O. Store at −20°C.
32. Pepsin:
a. Stock solution (10%) = 100 mg/mL, dissolve in sterile water, make 50-μL
aliquots, store at −20°C. Mix 20 μL pepsin in 100 mL prewarmed 0.01 N HCl
and adjust pH to 2.0. Incubate slides at 37°C for 5–10 min and wash slides in
1X PBS and 1X PBS/MgCl2 Store at −20°C.
33. Washing solution (pH 7.0):
a. 250 mL Formamide.
b. 50 mL 20X Saline sodium citrate (SSC).
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c. 200 mL ddH2O.
d. Stir well and adjust pH to 7.0 if necessary with 0.1 N HCl. Store at 4°C.
34. Common stock solutions (10):
a. 3 M Sodium acetate pH 5.2. Dissolve 408.1 g of sodium acetate·3H2O in 800 mL
of H2O. Adjust the pH to 5.2 with glacial acetic acid and sterilize by autoclaving.
b. PBS. Add 8 g NaCl, 200 mg KCl, 1.44 g Na2HPO4 (dibasic, anhydrous), and
240 mg KH2PO4 (monobasic, anhydrous) to 1 L H2O and adjust pH using HCl.
Sterilize by autoclaving.
c. 5 M Sodium chloride. Dissolve 292.2 g of NaCl in 800 mL of H2O; adjust vol-
ume to 1 L with H2O. Sterilize by autoclaving.
d. 20X SCC. Dissolve 175.3 g of NaCl and 88.2 g of sodium citrate in 800 mL
H2O. Adjust the pH to 7.0 with NaOH and make up to 1 L with H2O. Sterilize
by autoclaving. 
e. 1 M Tris-HCl, pH 7.2. Add 121 g of Tris base to 900 mL H2O. Adjust pH to 7.2
by adding 76 mL of HCl and adjust the volume to 1 L with H2O. Sterilize by
autoclaving. 
f. Nonidet P-40-sodium bicarbonate buffer (PN) buffer (pH 8.0): add 1 g sodium
bicarbonate and 5 mL of Nonidet P-40 to 900 mL-dH2O. Stir well and store at 4°C.
2.3. Tumor Chromosome Preparations for SKY and FISH
1. RPMI medium 1640 (GIBCO, cat. no. 21870-076).
2. L-Glutamine 200 mM (GIBCO, cat. no. 25030-081), 100 mL (make 5-mL aliquots;
add 5–500 mL medium).
3. Penicillin/streptomycin (GIBCO, cat. no. 15070-063) (make 5-mL aliquots; add
5–500 mL medium).
4. Fetal bovine serum qualified, heat inactivate (GIBCO, cat. no. 16140-071).
5. Colcemid, KaryoMAX Colcemid (10 μg/mL) (GIBCO, cat. no. 15210-040).
2.4. Spectral Karyotyping 
1. Formamide (Fisher, Pittsburg, PA; cat. no. F84-1).
2. DAPI (Sigma, cat. no. D-9542).




7. Water baths (37, 45, and 75°C).
8. Formaldehyde (Sigma, cat. no. F1268).
9. Glass slides, 22-mm2 and 24 × 50-mm2 cover slips.
10. Pepsin (Sigma, cat. no. P6887).
11. 1X PBS (Invitrogen, cat. no. 20012-027).
12. 1 M MgCl2 (Sigma, cat. no. M-1028).
13. PBD (PBS + Tween-20).
14. Human spectral karyotyping reagent (Applied Spectral Imaging, Visa, CA; cat. no.
SKY 000029).
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15. Mouse spectral karyotyping reagent (Applied Spectral Imaging, cat. no. SKY 000031).
16. Concentrated antibodies detection kit (CAD) (Applied Spectral Imaging, cat. no.
SKY 000133).
17. Tween-20 (Sigma, cat. no. P 5927).
18. 0.01 M HCl: 1 mL 1 M HCl in 99 mL dH2O. Prewarm to 37°C.
19. 4X SSC/Tween-20: add 100 mL 20X SSC and 0.5 mL Tween-20 in 400 mL dH2O
and heat for 30 min at 45°C.
20. PBS/MgCl2: add 50 mL 1 M MgCl2 to 950 mL dH2O.
21. 1% Formaldehyde: add 2.7 mL of 37% formaldehyde to100 mL PBS/MgCl2.
22. Pepsin stock:
a. See for details Subheading 2.2., item 32.
23. Denaturation solution (pH 7.0):
a. See for details Subheading 2.2., item 28.
24. Washing solution (pH 7.0):
a. See for details Subheading 2.2., item 33.
2.5. Preparation of Labeled DNA Probes for FISH
1. Spectrum Green-dUTP (50 nM) (Vysis, Des Plaines, IL; cat. no. 30-803200).
2. Spectrum Red-dUTP (50 nM) (Vysis, cat. no. 30-803400).
3. For other materials please refer to Subheading 2.2.
3. Methods
3.1. Comparative Genomic Hybridization
1. CGH is used in delineating chromosomal gains, losses, and amplifications of a
tumor genome by mapping these changes to a normal metaphase. CGH is based on
the competitive hybridization of differentially labeled normal (reference) and tumor
(test) DNA (1,11). The standard direct labeling protocol uses normal and tumor
DNA that has been labeled by incorporation of flurochrome-conjugated nucleotides.
An alternative method involves a slightly different procedure using normal and
tumor DNA that have been labeled with biotin or dioxigenin. This latter method
requires additional steps for detecting these labels with fluorochrome-conjugated
secondary agents. The repetitive sequences present in both genomes are suppressed
by adding an excess of unlabeled Cot-1 DNA to the hybridization mixture or copre-
cipitating with the differentially labeled tumor and normal genomic DNA.
Hybridized probes are detected with different colored fluorochromes (e.g., red and
green). The ratio of green to red fluorescence intensities along the length of the chro-
mosome reflects the relative amounts of DNA sequences in the test DNA.
Measuring the ratio of color intensities along the length of the chromosomes will
provide DNA copy number changes in the tumor genome. The labeled normal DNA
included in the hybridization process serves as a control for regional variations in the
ability to hybridize to the target chromosomes.
2. Although high-level amplifications are visible directly in a fluorescence microscope,
a quantitative measurement of fluorescence intensity values based on digital image
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analysis is crucial for a precise estimate of low copy-number changes. This analy-
sis includes image acquisition of a green and red fluorescence with a charge-cou-
pled device (CCD) camera. Using custom computer software, the painted
chromosomes are then segmented and the florescence values determined perpen-
dicular to the axis of the chromosome on a pixel-to-pixel basis. The result of meas-
urement of the fluorescence values can now be visualized by means of a value
table where certain colors refer to gains or losses in the tumor genome. The final
step in a quantitative fluorescence measurement includes the calculation of aver-
age ratio profiles along the chromosomal axis based on data from a minimum of
10 chromosomes (5 metaphase spreads). The average ratio of 1.0 indicates equal
copy numbers of the respective chromosomes, a ratio of 0.5 indicates a deletion of
one homologue and a ratio of 1.5 reflects a trisomy in the genome. Gene amplifi-
cation can be visualized as a peak fluorescence ratio of >2.0 and a localized sig-
nal to specific chromosome bands.
3.2. Preparation of Human Lymphocyte Metaphase Chromosomes
1. Prewarm 40 mL RPMI 1640 medium containing 20% fetal bovine serum (FBS),
1% L-glutamine, and 1% penicillin/streptomycin. Add 400 μL of PHA to the
medium.
2. Collect 10 mL of whole blood in a heparin tube (green top).
3. Spin 10 mL of blood at 250g (1500 rpm) for 10 min or let sit at room temperature for
2–3 h.
4. Collect 2 mL of supernatant (lymphocyte layer/buffy coat), distribute to two to three
T25 flasks or 15-mL tubes and culture for 72 h at 37°C (shake flasks once a day).
5. Add two drops of colcemid 2 h before harvesting using a 24-gauze needle (stock:
10 μg/mL).
6. Transfer to 15-mL tubes and centrifuge for 5 min at 250g (1500 rpm).
7. Remove supernatant and add 5 mL of prewarmed (37°C) 0.56% hypotonic solu-
tions (KCI) to each tube drop-by-drop, tapping tubes, and add more KCI to a total
volume of 10 mL.
8. Incubate at 37°C water bath for 15–20 min.
9. Centrifuge for 5 min at 1500 rpm (250g) and remove supernatant. 
10. Add 2 mL of freshly prepared fixative (3 methanol: 1 acetic acid) per tube drop-
by-drop by tapping tubes.
11. Add more fixative to total 10 mL/tube and let sit at room temperature for 1–2 h.
12. Centrifuge for 5 min at 1500 rpm (250g) and remove supernatant. Repeat steps
11–12 for three times.
13. Resuspend in 1–2 mL of fixative each tube (adjust the cell concentration depend-
ing on the size of the pellet).
14. Drop suspension onto clean glass slides (dip slides in ethanol and wipe with a
Kleenex tissue).
15. Check each batch of chromosome preparations for CGH and store at 4°C. (see
Note 2).
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3.3. Preparation of Labeled DNA Probes for CGH
High-molecular weight genomic DNA from a normal donor (reference DNA)
and a tumor (test DNA) is required for CGH. Several DNA extraction kits are
available commercially for genomic DNA preparation (QIAGEN, Promega).
Degraded DNA should be avoided because it will yield probes that are too small
upon nick translation, thereby resulting in poor-quality CGH (see Note 3).
The DNA extracted from microdissected tumor cells can be used for CGH.
However, the DNA isolated from these cells might be insufficient for CGH
analysis. Several whole genome amplification methods are currently available
to generate the large quantities of DNA that are required for CGH and other
genome screening methods (12).
3.3.1. Probe Labeling
1. To label test or reference DNA by nick translation add the reagents in the follow-
ing order:
a. 1 μg Test DNA or reference DNA in 38 μL dd H2O.
b. 5 μL 10X dNTP mix.
c. 1 μL dTTP mix. 
d. 1 μL Fluorescein isothiocynate (FITC) or Texas Red.
e. 5 μL Enzyme mix containing DNA polymerase I/DNase I.
f. 1 μL DNA polymerase I.
2. Mix contents of the tube well and incubate at 15°C for 1 h and 45 min. (The nick
translation time needs to be adjusted depending on the size of the genomic DNA.)
3. Place tubes on ice, while keeping them protected from light. 
4. Check the DNA fragment size by running a 1% agarose gel, using a 3-μL aliquot
of the reaction. 
5. Remove unincorporated nucleotides by running through a Sephadex G-50 column. 
6. If fragment size is in the appropriate range (500- to 3000-bp), heat the tubes at
75°C for 10 min, to inactivate the enzymes (see Note 4).
3.3.2. DNA Purification
1. Allow the G-50 Sephadex column to warm up to room temperature. Gently invert it
several times to resuspend the medium, while flicking it to remove any air bubbles. 
2. Remove the top cap from the column, followed by the bottom tip. This sequence
is absolutely necessary to avoid creating a vacuum, and uneven flow of buffer.
Place on a collection tube. Allow the buffer to drain by gravity and then discard
the elute.
3. Place the column and collection tube in a 15-mL centrifuge tube, and centrifuge
for 3 min at 3000 rpm in a swinging bucket rotor. Discard the eluted buffer.
4. Keeping the column in an upright position, carefully apply the DNA sample to the
center of the column bed.
5. Place the column on a second collection tube while keeping it in an upright 
position. Centrifuge for 3 min at 3000 rpm. Please note that speed and length of
centrifugation should be calibrated for individual centrifuges.
6. Collect the elute from the collection tube. This contains the purified DNA sample.
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3.3.3. Precipitation of Probe DNA for Hybridization
1. Add 40 μL FITC-labeled tumor DNA, 40 μL Texas Red-labeled normal reference
DNA, 20 μL Human Cot-1 DNA, 10 μL 3 M sodium acetate, and 400 μL cold
absolute ethanol.
2. Mix contents well and leave at −70°C for at least 1 h. 
3. Centrifuge at 14,000 rpm for 30 min at 4°C.
4. Remove the supernatant. A good size pellet should be visible at the bottom of
the tube.
5. Wash the pellet with 500 μL cold 70% ethanol.
6. Centrifuge at 14,000 rpm for 30 min at 4°C.
7. Remove the supernatant as thoroughly as possible. Air-dry pellet in the dark for at
least 2 h, until completely dry.
8. Resuspend the pellet in 10 μL hybridization mixture. Mix thoroughly by tapping
the bottom of the tube several times. Allow the pellet to dissolve over 2–3 h.
3.3.4. Slide Pretreatment
1. Pretreat all slides before use, for 1 h in 2X SSC at 37°C. 
2. Rinse slides in distilled water.
3. Treat the slides in series of ethanol (70, 80, and 100% absolute ethanol) for 
2 min each. Air-dry slides (see Note 5).
3.3.5. Slide Denaturation
1. Place the slides in denaturation solution (see Subheading 2.2., item 28) for 2 min
in a 74°C water bath in a Coplin jar. Denature only two slides at a time. 
2. After denaturation, immediately place the slides in ice cold 70% ethanol. Wash the
slides in 70, 80, and 100% ethanol for 2 min each. Air-dry the slides.
3.3.6. Probe Denaturation and Hybridization to Target Chromosomes
1. Denature the probe in a 74°C water bath for 6 min. 
2. Upon removal from the water bath, immediately apply the probe onto the slide and
place a 22-mm2 cover slip over the probe. 
3. Seal the edges of the cover slip with rubber cement. Up to two different hybridiza-
tions can be done on one slide, using half of the slide for each probe. It is useful
to note that, sealing the middle of the slide first will prevent the cover slip from
moving when applying the rubber cement.
4. Place the slides in a humidified chamber (Tupperware with paper towels mois-
tened with formamide solution). Incubate the slides at 37°C for 48 h.
3.3.7. Posthybridization Washes
1. Prewarm 50% formamide/2X SSC, 2X SSC, and 0.1% SSC in a 45°C water bath. 
2. Remove slides from the humid chamber and carefully remove rubber cement and
cover slips from the slide. 
3. Wash in 50% formamide/2X SSC for 10 min shaking intermittently. 
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4. Wash twice in 2X SSC for 5 min each. 
5. Wash once in 0.1X SSC for 5 min.
6. Wash slides once in 1X PN buffer for 5 min at room temperature.
7. Rinse in distilled water. Air-dry slides in the dark.
8. Apply 20 μL DAPI/antifade across the slide.
9. Cover the slide with a 24 × 50-mm2 cover slip.
3.3.8. Microscopy and Image Analysis for CGH
1. A fluorescence microscope equipped with a CCD camera and appropriate fil-
ters (DAPI, fluorescein, and Texas Red or rhodamine) is required to visualize
metaphase spreads hybridized with differentially labeled test and reference
DNA (Fig. 1A). The differences in the relative intensities of the two fluorochromes
can provide a color ratio profile indicative of copy-number changes in the test
DNA relative to the reference DNA. The following criteria is essential for high-
quality CGH, (1) well spread metaphase chromosomes with adequate length,
(2) uniform red and green hybridization (no granularity), (3) the red 
and green fluorescence distribution should be similar between two sister chrom-
atids, two homologous chromosomes and the same chromosome in all the
metaphases, (4) good DAPI banding for the identification of chromosomes, and
(5) background fluorescence level surrounding the chromosomes should be low
and uniform.
2. After direct visual inspection, the metaphase chromosomes are subjected to
quantitative analysis. This type of analysis can only be derived from digital
imaging. Several digital imaging systems are available commercially for CGH
analysis (Applied Imaging [San Jose, CA], Applied Spectral Imaging, Leica
Microsystems Inc. [Bannockburn, IN], and Metasystems [Watertown, MA]). By
digital imaging, first individual chromosomes will be segmented, local back-
ground subtracted, and the median axises of the chromosome defined (13,14).
These chromosomes will then be normalized to standard length and combined,
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Fig. 1. (Opposite page) Comparative genomic hybridization analysis. (A) A
metaphase spread after simultaneous hybridization with differentially labeled normal
(red) and tumor (medulloblastoma in this case) DNA (green) by CGH. Chromosomal
regions that were over-represented in the tumor are visualized in green, whereas regions
that were lost or deleted from the tumor are seen as red color. (B and C). Quantitative
analysis of CGH. (B) Chromosomes from Fig. 1A identified and karyotyped using quan-
titative imaging processing software (QUIPS, Applied Imaging). (C) Quantitative digital
image analysis of fluorescence intensity ratios. Green to red fluorescence ratio profiles is
shown for all chromosomes. The mean ratio (blue line) and ±1 SD (black lines) of 13–20
measurements for each chromosome are shown. The ratio profiles for each chromosome
are shown from pter to qter. The average value (1) representing the mean green to red ratio
for the entire case (6–10 metaphases) and red and green lines indicate threshold values of
0.8 and 1.2 for loss and gain, respectively.
a minimum of 10 chromosomes to show statistically the mean and 95 or 99% con-
fidence intervals of the red: green signal ratio. Control experiments (normal vs
normal DNAs) are very helpful for interpretation of CGH results from tumor sam-
ples with a particular batch of slides and reagents. Only ratio changes that exceed
the fluctuation seen in the control experiments are interpreted as evidence for real
loss or gain in the tumor compliment (Fig. 1B,C). The normal variation in a given
CGH experiment should not exceed ratios of 0.80–1.20 (±1 SD). In most cases,
the telomeric, peri-centromeric or heterochromatic regions fall outside this range
due to low signal intensities. Therefore, these regions should be excluded from the
analysis. In addition, caution should also be exercised in interpreting ratio changes
at 1p32-p36, 16p, 19, and 22 because of the high abnormal ratios in these regions.
Chromosomal amplifications can be detected as strong localized FITC signal at
the chromosomal site. For the precise assignment of amplification to chromoso-
mal bands, the peak of the ratio profile should be compared with corresponding
DAPI band of the same chromosome.
3.4. Tumor Chromosome Preparations for SKY and FISH
The investigation of karyotypic changes in tumor cells requires ability to
arrest cells at the metaphase stage, achieve spreading of the chromosomes to
finally study them under a microscope using an array of conventional and
molecular cytogenetics methods. Essentially, it is feasible to prepare chro-
mosomes from any actively dividing tumor cells. Conventional karyotypic
examination requires preparation of metaphases and staining by banding
methods to enable identification of individual chromosomes. Although there
are a number of techniques used for the recognition of specific chromosomal
structures or regions, the G-banding method has been the most accepted
technique. Owing to limitation of space it is recommended that the reader
refer to standard methods (15,16).
3.5. Spectral Karyotyping 
Conventional karyotype analysis is one of the widely accepted genome-
screening tools for identification of chromosomal aberrations in cancer cells.
However, metaphases with poor morphology and complexly rearranged marker
chromosomes, a common feature of tumor cells, are often difficult to interpret
unambiguously. The advent of multicolor FISH methods provides new ways to
identify precisely the nature of complex chromosome changes (4,5). This
method is based on the hybridization of combinatorially labeled chromosome-
specific painting probes to metaphase spreads, allowing simultaneous visuali-
zation of each chromosome pair by a unique color, in a single experiment. The
principle of multicolor FISH lies in labeling individual whole chromosome
probe pools in different fluorochromes or different ratios of fluorochromes
such that each chromosome ultimately displays a distinct color. Two distinctly
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different protocols have been developed for further analysis. One, termed mul-
tiplex FISH (m-FISH) (4), makes use of digital images acquired separately 
for each of five fluorochromes employed in labeling probes. The images are
acquired by use of appropriate filters and a CCD camera and analyzed by ded-
icated software that generates a composite image in which each chromosome is
pseudo-colored on the basis of the composition of fluorochrome(s) used. The
other procedure is SKY (5), which makes use of an entirely different system of
image acquisition from the probe-hybridized metaphase, which combines CCD
imaging with Fourier spectroscopy. The images are analyzed by dedicated soft-
ware, which generates composite images as in the case of m-FISH (Fig. 2). The
power of these new labeling and image acquisition/analysis techniques in the
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Fig. 2. SKY images of metaphase chromosomes from human (A and B) and mouse
(C and D) tumors with complex chromosomal rearrangements. (A and C) Spectra-based
display colors, (B and D) spectral classification from the same metaphase spreads.
definition of chromosomal changes in cancer cells are manifold. Thus, chromo-
somal breakpoints can be mapped and the composition of marker chromosomes
determined with high precision. However, the breakpoint determination on
painted chromosomes/inverted DAPI is often difficult mainly owing to the poor
chromosomal morphology after hybridization. Therefore, G-banded karyotypes
from the same tumor will be useful in determining breakpoints. 
3.5.1. Slide Pretreatment
1. Prepare chromosome spreads and mark the area of hybridization target with a dia-
mond pencil. 
2. Equilibrate the slides with 2X SSC for 30 min at RT. 
3. Rinse the slides in distilled water.
4. Dehydrate the slides in series of ethanol (70, 80, and 100% absolute ethanol) for
2 min each. Air-dry slides.
5. Slides that appear particularly cytoplasmic should undergo pepsin treatment.
6. Prewarm 50 mL of 0.01 M HCl in a Coplin jar at 37°C. Add 5–25 μL of pepsin
stock solution and mix well. Incubate slides at 37°C in a Coplin jar for 5–10 min. 
7. Wash slides in 1X PBS for 5 min at RT. Repeat the wash a second time in PBS.
8. Wash slides in 1X PBS/MgCl2 for 5 min at RT.
9. Incubate slides in 1% formaldehyde in 1X PBS/MgCl2 for 10 min at RT.
10. Wash slides in 1X PBS for 5 min at RT.
11. Dehydrate the slides in a series of 70, 80, and 100% absolute ethanol for 2 min each.
Air-dry slides (see Notes 7 and 8).
3.5.2. Slide Denaturation
1. Place the slides in denaturation solution (70% formamide/2X SSC) for 2 min in a
74°C water bath. Denature not more than two slides at a time. 
2. After denaturation, immediately place the slides in ice cold 70% ethanol. Pass slides
through 70, 80, and 100% ethanol for 2 min each. Air-dry the slides.
3.5.3. Probe Denaturation and Hybridization to Target Chromosomes
1. Denature the sky paint mixture in a 78–80°C water bath for 7 min and incubate in
a water bath at 37°C for 1 h.
2. Upon removal from the water bath, immediately apply the probe onto the slide and
place a 22-mm2 cover slip over the probe. 
3. Seal the edges of the cover slip with rubber cement. 
4. Place the slides in a humidified chamber (Tupperware with paper towels mois-
tened with formamide solution). 
5. Incubate the slides at 37°C for 48 h.
3.5.4. Posthybridization Washes
1. Prewarm 50% formamide/2X SSC, 1X SSC, and 4X SSC/0.1% Tween-20 in a
45°C water bath. 
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2. Remove the slides from humid chamber and carefully remove rubber cement and
cover slips from the slide. 
3. Wash twice in 50% formamide/2X SSC for 10 min each at 45°C. 
4. Wash twice in 1X SSC for 5 min each at 45°C. 
5. Wash once in 4X SSC/0.1% Tween-20 for 5 min at 45°C.
6. Rinse in distilled water at room temperature.
3.5.5. Detection
1. Take the slides out of the distilled water and drain well. Add 60 μL of vial no. 3
(supplied by ASI) over the specimen area and add a plastic cover slip. Place slides
in a humidified chamber and incubate at 37°C for 30 min. Adding blocking
reagent prior to this step is optional.
2. Wash slides three times in 4X SSC/0.1% Tween-20 for 5 min each.
3. Repeat step 1 with vial no. 4 (supplied by ASI) and incubate for 30 min in a
humidified chamber at 37°C.
4. Wash the slides three times in 4X SSC/0.1% Tween-20 for 5 min each.
5. Rinse the slides with distilled water for 2–3 min and air-dry the slides.
6. Place 15–20 μL of DAPI in antifade over the hybridized area and add a cover slip
of appropriate size. Now the slides are ready for capturing and analysis.
3.5.6. Microscopy and Image Analysis for SKY
SKY is based on spectral imaging, which is a combination of spectroscopy
and imaging. In contrast to conventional epifluorescence microscopy in which
flurochrome discrimination is based on the measurement of a single intensity
through fluorochromes with a specific optical filter, spectral imaging allows
one to measure and analyze the full spectrum of light at all given pixels of the
image. These images can be captured and analyzed using hardware and soft-
ware developed by applied spectral imaging (ASI).
3.6. Fluorescence In Situ Hybridization
FISH is a powerful molecular cytogenetic method based on the hybridization
of specific nucleic acid sequences to the target genome (8). The DNA or RNA
sequences are first labeled with reporter molecules and later the probe and the 
target, for example, chromosomes or nuclei are denatured. Complimentary
sequences in the probe and target are then allowed to reanneal. After washing and
incubation in fluorescently labeled affinity reagents, a discrete fluorescent signal
is visible at the site of probe hybridization. An alternate method for labeling is the
use of direct fluorochromes that incorporate into the DNA. This method does not
require additional steps for detecting labels with fluorochrome-conjugated sec-
ondary agents. Several reporter molecules, for example, red (Texas Red,
Spectrum Red, Cy 3) and green (FITC, Spectrum Green), are available for direct
labeling of DNA. Multicolor in situ hybridization is relatively new method, in
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Fig. 3. Partial metaphase spreads showing examples of hybridization of various types
of FISH probes. (A) A chromosomal arm probe (12p) labeled with Biotin and
hybridized to normal human metaphase chromosomes, (B) A complex ring chromo-
some in a case of malignant fibrous histocytoma. Whole chromosome painting
probes—WCP 17 (SpectrumOrange) and WCP 22 (SpectrumGreen) hybridized to
metaphase spreads derived from a malignant fibrous histiocytoma, (C) Alpha satellite
probe for chromosome 18 labeled with SpectrumRed hybridized to normal human
metaphase chromosomes, (D) Cy 3-labeled peptide nucleic acid (PNA) telomeric FISH
probe hybridized to human tumor chromosomes, (E) SpectrumGreen labeled single
copy DNA probe hybridized to human chromosome 1p31 region, (F) Biotin and dioxi-
genin labeled single copy DNA probes hybridized to human pachytene chromosome 6,
which several DNA probes can be labeled using different fluorochromes. This
method is based on the availability of fluorochromes, optical filters, and image
acquisition and registration software. Nick translation is the most common
method for the labeling of DNA probes. However, it is useful to label small
cDNA probes using the random priming method. Several DNA probes are com-
mercially available that include chromosome-specific repeats (centromeric and
telomeric), whole chromosome painting probes (WCP), chromosome arm probes,
and single-copy sequences (human DNA sequences cloned in plasmid, phage, cos-
mid, PAC, bacterial artificial chromosome [BAC], yeast artificial chromosome
vectors [YAC]) (Fig. 3). The relative position and orientation of clones along the
chromosomal axis can be visualized and quantified by FISH. The wide array of
currently available FISH techniques extends the resolution of visual mapping from
a few megabases to only a few kilobases (9,17) (Table 2).
3.6.1. Preparation of Plasmid, Phage, Cosmid, PAC, and BAC DNA for FISH
The DNA from any of the cloning vectors can be extracted using standard
alkaline lysis protocols or a Qiagen (Valencia, CA) plasmid purification kit. 
3.6.2. Preparation of Labeled DNA Probes for FISH (Probe Labeling)
1. To label Plasmid/Phage/Cosmid/PAC/BAC DNA by nick translation add the
reagents in the following order:
a. 1 μg DNA in ddH2O (make up to 50 μL of total reaction volume).
b. 5 μL 10X dNTP mix.
c. 1 μL dTTP mix.
d. 1 μL Spectrum Green or Spectrum Red.
e. 5 μL Enzyme mix containing DNA polymerase I/DNase I.
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Fig. 3. (Continued) (G) Identification of gene amplification in mouse breast cancer
model. A BAC clone containing the Met gene labeled with SpectrumOrange and
hybridized to metaphase chromosomes derived from mouse breast cancer cells. Multiple
copies of double min are shown. Inset shows homogenously stained region with multi-
ple copies of Met gene.
Table 2
Comparison of Sensitivity of Various FISH Mapping Techniques
Source Resolution
Metaphase chromosomes >1 mb
Mechanically stretched chromosomes >200 kb
Pachytene chromosomes ~380–500 kb
Interphase nuclei ~50-kb–1 mb
DNA fibers ~1–500 kb
2. Mix contents of the tube well and incubate at 15°C for 1 h and 45 min. (The nick
translation time can be adjusted depending upon the size of the genomic DNA.
The bigger the probe the longer the requirement of incubation time.)
3. Place tubes on ice, while keeping them protected from light. 
4. Check the DNA fragment size by running a 1% agarose gel, using a 2- to 3-μL
aliquot of the reaction. 
5. Heat the tubes at 75°C for 10 min, to inactivate the enzymes (see Note 9).
3.6.3. Precipitation of Probe DNA for Hybridization
1. Add the following contents to the nick translation reaction mix before precipitation:
a. 5 mL Human Cot-1 DNA (for YACs, BACs, and PACs to suppress the repetitive
sequences).
b. 5 μL 3 M Sodium acetate.
c. 300 μL Cold absolute ethanol.
2. Mix contents well and leave at –70°C for at least 1 h. 
3. Centrifuge at 14,000 rpm for 30 min at 4°C.
4. Remove supernatant. A good size pellet should be visible at the bottom of the tube.
5. Wash the pellet with 500 μL cold 70% ethanol.
6. Centrifuge at 14,000 rpm for 30 min at 4°C.
7. Remove the supernatant as thoroughly as possible. Air-dry the pellet in the dark
for at least 2 h, or until completely dried.
8. Resuspend the pellet in 10 μL ddH2O. Mix thoroughly by tapping the bottom of
the tube several times. Allow the pellet to dissolve over 1 h. When ready to carry
out hybridization, prepare probe mixture by dissolving 2–3 μL of labeled DNA in
10 μL of hybridization mixture.
3.6.4. Slide Pretreatment
1. Pretreat all slides before use, for 1 h in 2X SSC at 37°C. 
2. Rinse the slides in distilled water.
3. Treat the slides in 70, 80, and 100% absolute ethanol series for 2 min each.
4. Air-dry the slides. Please note that, metaphase spreads that appear particularly
cytoplasmic should undergo pepsin treatment.
3.6.5. Slide Denaturation
1. Place the slides in denaturation solution (70% formamide/2X SSC) for 2 min in a
74°C water bath. Denature a maximum of two slides at a time. 
2. After denaturation, immediately place the slides in ice cold 70% ethanol. Wash the
slides in 70, 80, and 100% ethanol for 2 min each.
3. Air-dry the slides.
3.6.6. Probe Denaturation and Hybridization to Target Chromosomes
1. Denature the probe in a 74°C water bath for 6 min. 
2. Upon removal from the water bath, immediately apply the probe onto the slide and
place a 22-mm2 cover slip over the probe. 
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3. Seal the edges of the cover slip with rubber cement. 
4. Place the slides in a humidified chamber (Tupperware with paper towels mois-
tened with formamide solution). Incubate the slides at 37°C for 24 h.
3.6.7. Posthybridization Washes
1. Prewarm 50% formamide/2X SSC, 2X SSC, and 0.1% SSC in a 45°C water bath. 
2. Remove the slides from humid chamber and carefully remove rubber cement and
cover slips from the slide. 
3. Wash in 50% formamide/2X SSC for 10 min. 
4. Wash twice in 2X SSC for 5 min each. 
5. Wash once in 0.1X SSC for 5 min.
6. Wash the slides once in 1X PN buffer for 5 min at room temperature.
7. Rinse in distilled water.
8. Air-dry the slides in the dark.
9. Apply 20 μL DAPI/antifade across the slide.
10. Cover the slide with a 24 × 50-mm2 cover slip.
3.6.8. Microscopy and Image Analysis for FISH
A laboratory that focuses mainly on single copy gene mapping on interphase,
metaphase or prophase chromosomes, a fluorescence microscope equipped with
dual band pass filter or triple band pass filter for the simultaneous visualization of
multiple probes or paints is required. Several digital imaging systems are avail-
able commercially for FISH/CGH, for example, Applied Imaging, Metasystems,
Applied Spectral Imaging, and Leica.
3.7. Future Perspective
Our current awareness of chromosome abnormalities in cancers has per-
mitted simultaneous detection of multiple abnormalities using multicolor-
multiplex FISH-type tests using the technologies described in this chapter.
The combination of conventional and molecular cytogenetic methods of
analyses will remain methods of choice in diagnosis and classification of
malignant diseases into clinically and biologically relevant classes. With the
availability of genome sequences of various organisms, including human,
refined genome-wide screening approaches to define the cytogenetic
changes such as microarray technologies will gain importance in both clini-
cal and research scenarios. These technologies will ultimately provide per-
sonalized genetic diagnosis and treatment a reality.
4. Notes
1. Check the activity of DNase on normal DNA.
2. The quality of metaphase spreads is crucial for CGH. The criteria for superior
quality metaphase preparations include medium density, well spread, slight or no
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cytoplasm, and little debris on the slide. It is better to avoid chromosomes that
appear bright or hollow. Sometimes synchronized chromosome preparations will
give granularity on the chromosomes and this can adversely affect the fluores-
cence ratios.
3. The percentage of tumor cells in the specimen is critical for detecting chromosomal
copy-number changes in cancer. If the tumor cell content in the tissue is less than
40%, the resulting CGH karyotype will be normal. In those cases, the tumors’ cells
can be microdissected using laser capture microscope (Palm Laser-MicroBeam
System, Wolfratshausen, Germany or Pix Cell II, Arcturus Biosciences, Inc.,
Mountain View, CA).
4. Optimum DNA fragment size is in the range of 500 to 3000 bp. If fragment size
is larger than 3000 bp, continue the incubation for another 15–20 min after adding
1–2 μL of a DNase working solution, if necessary.
5. Metaphase spreads that appear particularly cytoplasmic should be subjected to
pepsin treatment.
6. CGH was the first high-throughput whole genome analysis methods for estimat-
ing DNA copy-number changes in the entire genome in a single experiment.
Particular advantage of this method is that DNA from tumor specimens can be
used to circumvent the need for tumor metaphases. CGH can be performed on
good quality DNA isolated from any form of tissue, fresh, frozen, or archival. 
7. The quality of metaphase spreads is crucial for SKY. The criteria for superior qual-
ity metaphase preparations include well spread, slight or no cytoplasm and little
debris on the slide. It is better to avoid chromosomes that appear bright or hollow.
The timing of pepsin treatment varies from sample to sample and therefore, it is bet-
ter to evaluate pepsin digest placing a 24 × 60-mm2 cover slip under phase-contrast
microscope. If excessive cytoplasm remain around the metaphase chromosomes,
additional treatment with pepsin is necessary.
8. SKY on previously G-banded metaphase preparations is possible and the results
obtained can be with similar hybridization intensities to slides that were not sub-
jected to G-banding. Before doing SKY, the slides should go through xylene and
methanol treatment. Previously G-banded chromosomes need a shorter denatura-
tion time (15–30 s).
9. Optimum DNA fragment size is in the range of 100 to 500 bp. If fragment size is
larger than 500 bp, continue the incubation for another 15–20 min after adding 
1–2 μL of a DNase working solution, if necessary.
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